Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease

Observational studies indicate that selenium may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Transcriptomic exploration of the aetiology and progression of NAFLD may offer insight into the role selenium plays in this disease. This study compared gene expression level...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaitlin Day, Lucia A. Seale, Ross M. Graham, Barbara R. Cardoso
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/fe723a87500e4b72b2c8090ef0e53873
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe723a87500e4b72b2c8090ef0e53873
record_format dspace
spelling oai:doaj.org-article:fe723a87500e4b72b2c8090ef0e538732021-11-17T06:36:42ZSelenotranscriptome Network in Non-alcoholic Fatty Liver Disease2296-861X10.3389/fnut.2021.744825https://doaj.org/article/fe723a87500e4b72b2c8090ef0e538732021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnut.2021.744825/fullhttps://doaj.org/toc/2296-861XObservational studies indicate that selenium may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Transcriptomic exploration of the aetiology and progression of NAFLD may offer insight into the role selenium plays in this disease. This study compared gene expression levels of known selenoprotein pathways between individuals with a healthy liver to those with NAFLD. Publicly available gene expression databases were searched for studies that measured global gene expression in liver samples from patients with steatosis and non-alcoholic steatohepatitis (NASH) and healthy controls (with [HOC] or without [HC] obesity). A subset of five selenoprotein-related pathways (164 genes) were assessed in the four datasets included in this analysis. The gene TXNRD3 was less expressed in both disease groups when compared with HOC. SCLY and SELENOO were less expressed in NASH when compared with HC. SELENOM, DIO1, GPX2, and GPX3 were highly expressed in NASH when compared to HOC. Disease groups had lower expression of iron-associated transporters and higher expression of ferritin-encoding sub-units, consistent with dysregulation of iron metabolism often observed in NAFLD. Our bioinformatics analysis suggests that the NAFLD liver may have lower selenium levels than a disease-free liver, which may be associated with a disrupted iron metabolism. Our findings indicate that gene expression variation may be associated with the progressive risk of NAFLD.Kaitlin DayLucia A. SealeRoss M. GrahamBarbara R. CardosoFrontiers Media S.A.articleseleniumnon-alcoholic steatohepatitisselenoproteinsselenocysteine lyaseferroptosisNutrition. Foods and food supplyTX341-641ENFrontiers in Nutrition, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic selenium
non-alcoholic steatohepatitis
selenoproteins
selenocysteine lyase
ferroptosis
Nutrition. Foods and food supply
TX341-641
spellingShingle selenium
non-alcoholic steatohepatitis
selenoproteins
selenocysteine lyase
ferroptosis
Nutrition. Foods and food supply
TX341-641
Kaitlin Day
Lucia A. Seale
Ross M. Graham
Barbara R. Cardoso
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
description Observational studies indicate that selenium may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Transcriptomic exploration of the aetiology and progression of NAFLD may offer insight into the role selenium plays in this disease. This study compared gene expression levels of known selenoprotein pathways between individuals with a healthy liver to those with NAFLD. Publicly available gene expression databases were searched for studies that measured global gene expression in liver samples from patients with steatosis and non-alcoholic steatohepatitis (NASH) and healthy controls (with [HOC] or without [HC] obesity). A subset of five selenoprotein-related pathways (164 genes) were assessed in the four datasets included in this analysis. The gene TXNRD3 was less expressed in both disease groups when compared with HOC. SCLY and SELENOO were less expressed in NASH when compared with HC. SELENOM, DIO1, GPX2, and GPX3 were highly expressed in NASH when compared to HOC. Disease groups had lower expression of iron-associated transporters and higher expression of ferritin-encoding sub-units, consistent with dysregulation of iron metabolism often observed in NAFLD. Our bioinformatics analysis suggests that the NAFLD liver may have lower selenium levels than a disease-free liver, which may be associated with a disrupted iron metabolism. Our findings indicate that gene expression variation may be associated with the progressive risk of NAFLD.
format article
author Kaitlin Day
Lucia A. Seale
Ross M. Graham
Barbara R. Cardoso
author_facet Kaitlin Day
Lucia A. Seale
Ross M. Graham
Barbara R. Cardoso
author_sort Kaitlin Day
title Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
title_short Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
title_full Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
title_fullStr Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
title_full_unstemmed Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
title_sort selenotranscriptome network in non-alcoholic fatty liver disease
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/fe723a87500e4b72b2c8090ef0e53873
work_keys_str_mv AT kaitlinday selenotranscriptomenetworkinnonalcoholicfattyliverdisease
AT luciaaseale selenotranscriptomenetworkinnonalcoholicfattyliverdisease
AT rossmgraham selenotranscriptomenetworkinnonalcoholicfattyliverdisease
AT barbararcardoso selenotranscriptomenetworkinnonalcoholicfattyliverdisease
_version_ 1718425904248520704